FRS2 and neoplasm: Molecular profiling of the primary tumor revealed alterations, including amplifications in MDM2, ERBB3, ARAF, CDK4, and EGFR and alterations in PIK3CA, FRS2, GLI1, and IKZF1. TMB was low and microsatellite stable.